Disclosure Policy

The American Society for Nutrition supports fair and unbiased participation of individuals in its education activities. Any real or potential conflicts of interest must be identified and managed. All relevant financial relationships with commercial interests that directly impact and/or might conflict with ASN activities must be disclosed, or disclosure that no relevant financial relationships exist must be documented. Other relationships that could cause private interests to conflict with professional interests must also be disclosed. This policy is intended to openly identify any potential conflict so that participants in an education activity are able to form their own judgments about the presentation. In addition, disclosure must be made of presentations on drugs or devices or uses of drugs or devices that have not been approved by the Food and Drug Administration. 

Speakers

John Buse, MD, PhD, Verne S. Caviness Distinguished Professor; Chief, Division of Endocrinology, University of North Carolina School of Medicine
Disclosures: Grant/Research Support: Dexcom, NovaTarg, Novo Nordisk, Sanofi, Tolerion, vTv Therapeutics; Consultant: Alkahest, Altimmune, Anji, AstraZeneca, Bayer, Biomea Fusion Inc, Boehringer-Ingelheim, CeQur, Cirius Therapeutics Inc, Eli Lilly, GentiBio, Glycadia, Glyscend, Janssen, MannKind, Mellitus Health, Moderna, Novo Nordisk, Pendulum Therapeutics, Praetego, Stability Health, Valo, Zealand Pharma; Stock: Glyscend, Mellitus Health, Pendulum Therapeutics, PhaseBio, Praetego, Stability Health
All of the relevant financial relationships listed for this individual have been mitigated.  

Ania Jastreboff, MD, PhD, Associate Professor of Medicine, Endocrinology & Metabolism, Yale University School of Medicine
Disclosures: Consultant: Boehringer Ingelheim, Eli Lilly, Intellihealth, Novo Nordisk, Novo Nordisk AS, Pfizer, Rhythm Pharmaceuticals, Scholar Rock, WWF International; Grant/Research Support: Eli Lilly, Novo Nordisk, Rhythm Pharmaceuticals
All of the relevant financial relationships listed for this individual have been mitigated.  

Richard Kahn, PhD, Department of Medicine, University of North Carolina, Chapel Hill
Disclosure(s): Abbott: Consultant: Abbott
All of the relevant financial relationships listed for this individual have been mitigated. 

Planners

Sahar Ajabshir, PhD, Florida International University
No relevant financial relationship(s) with ineligible companies to disclose.

Ann Anderson-Berry, MD, PhD, University of Nebraska Medical
Disclosures: Center Data and Safety Monitoring Committee: Pfizer
All of the relevant financial relationships listed for this individual have been mitigated.  

Cora Best, PhD, MHS, RDN, University of Washington School of Medicine
No relevant financial relationship(s) with ineligible companies to disclose.

Yanbin Dong, PhD, Augusta University
No relevant financial relationship(s) with ineligible companies to disclose.

Roschelle Heuberger, PhD, RD, Central Michigan University
No relevant financial relationship(s) with ineligible companies to disclose.

David Seres, MD, ScM, PNS, FASPEN, Columbia University
Disclosures: Consultant: Community Surgical, Fresenius-Kabi  
All of the relevant financial relationships listed for this individual have been mitigated.  

Christy Tangney, PhD, MS, Rush Medical College
No relevant financial relationship(s) with ineligible companies to disclose.

Staff

Michelle Crispino, CAE, DES, American Society for Nutrition
No relevant financial relationship(s) with ineligible companies to disclose.

Gwen Twillman, American Society for Nutrition
No relevant financial relationship(s) with ineligible companies to disclose.